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Backgrownd. Nowadays evidence is an absolutely essential criterion for the practical use of any knowledge while providing a medical practice. Any therapeutic intervention should not be only theoretically substantiated, but its effectiveness must be confirmed by large studies that comply the requirements of the evidence-based medicine.
Objective. To demonstrate the defects and problems arising from the neglect of the principles of evidence-based medicine by the example of narcological care services.
The term "evidence-based medicine" was introduced in the end of the twentieth century to denote the medical practice, based on data from methodologically correct, entirely scientific clinical studies. Evidence-based treatment standards have taken root in many fields of medicine. Meanwhile, in some fields this process significantly lags behind the general trends. In particular, in the countries of the former Soviet Union one of these sectors is a narcology.
Standards of medical care approved by the authorities of the state health service for the most part are based on advanced international developments, approved and recommended by WHO for implementation in clinical practice. This allows to maximize the effectiveness of therapeutic activity of a doctor.
A real crisis of evidence takes place in the field of narcological care of patients with opiate addiction in Russian Federation. To date, the standard therapeutic tactic of the treatment of patients suffering from the syndrome of opiate dependence in Russia is the use of opioid receptor antagonists (naloxone, naltrexone) in combination with neuroleptics, antidepressants and anticonvulsants. These psychotropic drugs in russian official health care standards are defined as "the specific medications for suppression of craving to a drug". At the same time there is a huge evidence base of an inefficiency of this form of treatment. A meta-analysis of a group of randomized placebo-controlled trials of oral form of naltrexone (1158 subjects, class of evidence - I) published by Cochrane Collaboration did not show any advantages of this type of treatment both for management and prevention of relapse compared with placebo [6]. Neuroleptics are also not found to be effective for the direct treatment of the opiate dependence syndrom, and their use is justified only in case of psychiatric comorbidity in patients [4, 5], and in WHO documents and standards of addicted patients treatment in other countries these psychotropic drugs are assigned to a group of auxiliary medications. The world's advanced tactics of management and prevention of relapse of opiate dependence is the maintenance therapy with opioid agonists (methadone, buprenorphine). A great confirmation of this is the Cochrane Review with data based on 146 scientific studies involving 21,404 patients (class of evidence - I) proving the effectiveness of opioid receptor agonists for the treatment of opiate dependence.
So there is a paradox: the Russian law strictly prohibits the use of opioid agonists, which makes it impossible to perform inland trials of this method of treatment as the scientific evidence requires. As a result narcologists are not allowed to use the best treatment tactics, and patients are unable to get the entire amount of modern medical care available to patients in other countries and included in the international standards of treatment. Eventually, in view of these and some other disadvantages of the Drug Service standards arising from the neglect of the principles of evidence-based medicine, we can see the following statistics: effectiveness of the opiate addiction treatment demonstrated by the 1-year remission criterion is 9.2% in Russia, 30-35% in the world practice [1].
The situation in Ukraine is somewhat different. Ukrainian Ministry of Health aims to create normative acts on the basis of the latest WHO recommendations. Unfortunately, due to the lack of sufficiently large inland evidence-based researches, the vast majority of treatment protocols for patients with the dependence syndrome has a class of evidence IV - a consensus developed by a group of experts on a particular issue [2]. Regarding the program of substitutional treatment using opioid agonists, in Ukraine in 2013 its coverage was 7000 patients - 2.6% of the estimated 280000 (380000) injecting drug users, that is caused by the lack of funding and other factors [3].
Conclusions. Ignoring the principles of evidence-based medicine at present significantly reduces the quality and efficiency of medical care provided to patients, which is well demonstrated on the example of the functioning of narcological care services in different countries.
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